SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4. (2018)

First Author: Tzelepis K
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-018-07620-0

PubMed Identifier: 30568163

Publication URI: http://europepmc.org/abstract/MED/30568163

Type: Journal Article/Review

Volume: 9

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723